Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients
A phase 2 trial of Paclitaxel / nab-paclitaxel and Iniparib in Breast cancer, run by Sanofi, completed.
Overview
Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients is a phase 2 interventional study registered as NCT01204125 by Sanofi, with 141 participants recorded, started 2010-09 and reaching its primary completion in 2012-10. Interventions recorded: paclitaxel, Iniparib (SAR2405550 -BSI-201). Conditions recorded: Breast Cancer Female.
Linked to the drug Iniparib because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialA Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer
Shares Iniparib, Sanofi, Breast cancer (all types) and the tag pipeline.
- TrialStudy of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer
Shares Iniparib, Sanofi, Breast cancer (all types) and the tag pipeline.
- TrialTusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors
Shares Sanofi, Breast cancer (all types) and the tag pipeline.
- TrialAbraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer
Shares Breast cancer (all types), Paclitaxel / nab-paclitaxel and the tag pipeline.
- TrialChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Shares Breast cancer (all types), Paclitaxel / nab-paclitaxel and the tag pipeline.
- TrialMobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
Shares Sanofi and the tag pipeline.
- TrialMARGetuximab Or Trastuzumab (MARGOT)
Shares Breast cancer (all types), Paclitaxel / nab-paclitaxel and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.